QR-Code

Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies

Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD) and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance cholinergic and dopaminergic neurotransmission in AD and PD, respectively, and few studies have examined noradrenergic dysfuncti...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Hauptverfasser: Andrew C. Peterson, Chiang-shan R. Li
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2018-05-01
Schriftenreihe:Frontiers in Aging Neuroscience
Schlagworte:
Online-Zugang:http://journal.frontiersin.org/article/10.3389/fnagi.2018.00127/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!